Determination of Drug Interactions of Certain Nasal Medications With Intranasal Ketamine
Determination of Drug Interactions of Certain Nasal Medications With Intranasal Ketamine
This is an open label, single-center study to determine whether certain nasal medication
 interact with PMI-150 (intranasal ketamine) 30 mg in healthy adult volunteers and in patients
 with allergic rhinitis.
To assess separately the effects of a nasal vasoconstrictor (oxymetazoline) and of a nasal
 steroid on the rate and extent of intranasal absorption of PMI-150 30 mg.
Inclusion Criteria:

 -  Healthy adults

 -  Patients with Allergic Rhinitis

 Exclusion Criteria:

 -  Under age 18